Literature DB >> 11451680

Overexpression and characterization of the chromosomal aminoglycoside 2'-N-acetyltransferase of Providencia stuartii.

K Franklin1, A J Clarke.   

Abstract

The gene coding for aminoglycoside 2'-N-acetyltransferase Ia [AAC(2')-Ia] from Providencia stuartii was amplified by PCR and cloned. The resulting construct, pACKF2, was transferred into Escherichia coli for overexpression of AAC(2')-Ia as a fusion protein with an N-terminal hexa-His tag. The fusion protein was isolated and purified by affinity chromatography on Ni(2+)-nitrilotriacetic acid agarose and gel permeation chromatography on Superdex 75. Comparison of the specific activity of this enzyme with that of its enterokinase-digested derivative lacking the His tag indicated that the presence of the extra N-terminal peptide does not affect activity. The temperature and pH optima for activity of both forms of the 2'-N-acetyltransferase were 20 degrees C and pH 6.0, respectively, while the enzymes were most stable at 15 degrees C and pH 8.1. The Michaelis-Menten kinetic parameters for AAC(2')-Ia at 20 degrees C and pH 6.0 were determined using a series of aminoglycoside antibiotics possessing a 2'-amino group and a concentration of acetyl coenzyme A fixed at 10 times its K(m) value of 8.75 microM. Under these conditions, gentamicin was determined to be the best substrate for the enzyme in terms of both K(m) and k(cat)/K(m) values, whereas neomycin was the poorest. Comparison of the kinetic parameters obtained with the different aminoglycosides indicated that their hexopyranosyl residues provided the most important binding sites for AAC(2')-Ia activity, while the enzyme exhibits greater tolerance further from these sites. No correlation was found between these kinetic parameters and MICs determined for P. stuartii PR50 expressing the 2'-N-acetyltransferase, suggesting that its true in vivo function is not as a resistance factor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451680      PMCID: PMC90637          DOI: 10.1128/AAC.45.8.2238-2244.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  A 2'-N-acetylating enzyme of aminoglycosides.

Authors:  M Yamaguchi; S Mitsuhashi; F Kobayashi; H Zenda
Journal:  J Antibiot (Tokyo)       Date:  1974-07       Impact factor: 2.649

2.  Enzymatic acetylation of aminoglycoside antibiotics by Escherichia coli carrying an R factor.

Authors:  R Benveniste; J Davies
Journal:  Biochemistry       Date:  1971-05-11       Impact factor: 3.162

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Correlation of antibiotic resistance with Vmax/Km ratio of enzymatic modification of aminoglycosides by kanamycin acetyltransferase.

Authors:  K Radika; D B Northrop
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

5.  Kinetic mechanisms of gentamicin acetyltransferase I. Antibiotic-dependent shift from rapid to nonrapid equilibrium random mechanisms.

Authors:  J W Williams; D B Northrop
Journal:  J Biol Chem       Date:  1978-09-10       Impact factor: 5.157

6.  Aminoglycoside 2'-N-acetyltransferase genes are universally present in mycobacteria: characterization of the aac(2')-Ic gene from Mycobacterium tuberculosis and the aac(2')-Id gene from Mycobacterium smegmatis.

Authors:  J A Aínsa; E Pérez; V Pelicic; F X Berthet; B Gicquel; C Martín
Journal:  Mol Microbiol       Date:  1997-04       Impact factor: 3.501

7.  The role of O-acetylation in the metabolism of peptidoglycan in Providencia stuartii.

Authors:  K G Payie; H Strating; A J Clarke
Journal:  Microb Drug Resist       Date:  1996       Impact factor: 3.431

8.  Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-beta-lactamase IMP-1 produced by Escherichia coli.

Authors:  N Laraki; N Franceschini; G M Rossolini; P Santucci; C Meunier; E de Pauw; G Amicosante; J M Frère; M Galleni
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

9.  Aminoglycoside resistance in Mycobacterium kansasii, Mycobacterium avium-M. intracellulare, and Mycobacterium fortuitum: are aminoglycoside-modifying enzymes responsible?

Authors:  I I Ho; C Y Chan; A F Cheng
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

10.  Aminoglycoside resistance in bacteria medicated by gentamicin acetyltransferase II, an enzyme modifying the 2'-amino group of aminoglycoside antibiotics.

Authors:  M Chevereau; P J Daniels; J Davies; F LeGoffic
Journal:  Biochemistry       Date:  1974-01-29       Impact factor: 3.162

View more
  10 in total

1.  Evolution of an incompatibility group IncA/C plasmid harboring blaCMY-16 and qnrA6 genes and its transfer through three clones of Providencia stuartii during a two-year outbreak in a Tunisian burn unit.

Authors:  C Arpin; L Thabet; H Yassine; A A Messadi; J Boukadida; V Dubois; L Coulange-Mayonnove; C Andre; C Quentin
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 2.  Aminoglycoside modifying enzymes.

Authors:  Maria S Ramirez; Marcelo E Tolmasky
Journal:  Drug Resist Updat       Date:  2010-09-15       Impact factor: 18.500

3.  Implication of porins in beta-lactam resistance of Providencia stuartii.

Authors:  Que-Tien Tran; Kozhinjampara R Mahendran; Eric Hajjar; Matteo Ceccarelli; Anne Davin-Regli; Mathias Winterhalter; Helge Weingart; Jean-Marie Pagès
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

Review 4.  Small-Molecule Acetylation by GCN5-Related N-Acetyltransferases in Bacteria.

Authors:  Rachel M Burckhardt; Jorge C Escalante-Semerena
Journal:  Microbiol Mol Biol Rev       Date:  2020-04-15       Impact factor: 11.056

Review 5.  Versatility of aminoglycosides and prospects for their future.

Authors:  Sergei B Vakulenko; Shahriar Mobashery
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

6.  Enterococcus faecalis constitutes an unusual bacterial model in lysozyme resistance.

Authors:  Laurent Hébert; Pascal Courtin; Riccardo Torelli; Maurizio Sanguinetti; Marie-Pierre Chapot-Chartier; Yanick Auffray; Abdellah Benachour
Journal:  Infect Immun       Date:  2007-09-04       Impact factor: 3.441

7.  In Vitro Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli.

Authors:  Wim A Fleischmann; Kerryl E Greenwood-Quaintance; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

8.  Class 1 integrons in environments with different degrees of urbanization.

Authors:  Maximiliano Nardelli; Paula Marina Scalzo; María Soledad Ramírez; María Paula Quiroga; Marcelo Hernán Cassini; Daniela Centrón
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

9.  Structural and biochemical analyses of an aminoglycoside 2'-N-acetyltransferase from Mycolicibacterium smegmatis.

Authors:  Chang-Sook Jeong; Jisub Hwang; Hackwon Do; Sun-Shin Cha; Tae-Jin Oh; Hak Jun Kim; Hyun Ho Park; Jun Hyuck Lee
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

10.  Mycobacterium Time-Series Genome Analysis Identifies AAC2' as a Potential Drug Target with Naloxone Showing Potential Bait Drug Synergism.

Authors:  Vidya Niranjan; Akshay Uttarkar; Keerthana Murali; Swarna Niranjan; Jayalatha Gopal; Jitendra Kumar
Journal:  Molecules       Date:  2022-09-20       Impact factor: 4.927

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.